Literature DB >> 17203586

Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle-only dementia): the Hisayama Study.

Kazuhito Noda1, Kensuke Sasaki, Kohei Fujimi, Yoshinobu Wakisaka, Yumihiro Tanizaki, Yoshiyuki Wakugawa, Yutaka Kiyohara, Mitsuo Iida, Hisamiti Aizawa, Toru Iwaki.   

Abstract

Senile dementia of the neurofibrillary tangle type (SD-NFT) is characterized by numerous neurofibrillary tangles (NFT) in the hippocampal region and the absence or minimal presence of senile plaques throughout the brain. We analyzed 207 demented subjects and 68 non-demented subjects autopsied in the Hisayama study to investigate the clinicopathological aspects of SD-NFF in the general Japanese population. The prevalence of SD-NFT in the consecutive autopsy cases was 8/207 (3.9%), comprising three men and five women. The average age at onset and death was 83.8 +/- 6.8 (mean +/- SD; standard deviation) and 88.1 +/- 7.6 years, respectively. A mild memory disturbance preceded a decrease in the ability to undertake the activities of daily living and the diagnosis of dementia. Focal cerebral symptoms, such as aphasia and paralysis, did not appear during the disease course of any subject. Gross examination of the brains showed moderate to severe diffuse cerebral atrophy with brain weight loss (mean +/- SD; standard deviation: 1118.1 +/- 124.0 g). Histologically, there were abundant NFT and neuropil threads predominantly in or limited to the limbic cortex. The density of NFT in the CA1/subiculum in SD-NFT was much higher than the densities in the other hippocampal regions. The average density of NFT in CA1 in SD-NFT subjects was 115.4 per 100 x field (range 23-247), that in Alzheimer disease (AD) subjects was 80.1 (range 1-227), and that in non-demented elderly subjects was 37.2 (range 0-203). Although many previous papers have reported that the densities of NFT in the limbic system in SD-NFT were significantly higher than those in AD, there was considerable overlap of NFT densities in CA1 among the non-demented elderly, AD subjects and SD-NFT subjects.

Entities:  

Mesh:

Year:  2006        PMID: 17203586     DOI: 10.1111/j.1440-1789.2006.00722.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  20 in total

Review 1.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

2.  The MAPT H1 haplotype is associated with tangle-predominant dementia.

Authors:  Ismael Santa-Maria; Aya Haggiagi; Xinmin Liu; Jessica Wasserscheid; Peter T Nelson; Ken Dewar; Lorraine N Clark; John F Crary
Journal:  Acta Neuropathol       Date:  2012-07-17       Impact factor: 17.088

3.  Antemortem Prediction of Braak Stage.

Authors:  Jesper O E Carlson; Margaret Gatz; Nancy L Pedersen; Caroline Graff; Inger Nennesmo; Anna-Karin Lindström; Lotte Gerritsen
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

4.  Effects of glucocorticoids on age-related impairments of hippocampal structure and function in mice.

Authors:  Wen-Bin He; Jun-Long Zhang; Jin-Feng Hu; Yun Zhang; Takeo Machida; Nai-Hong Chen
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

5.  Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.

Authors:  Nicholas J Janocko; Kevin A Brodersen; Alexandra I Soto-Ortolaza; Owen A Ross; Amanda M Liesinger; Ranjan Duara; Neill R Graff-Radford; Dennis W Dickson; Melissa E Murray
Journal:  Acta Neuropathol       Date:  2012-09-12       Impact factor: 17.088

6.  Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.

Authors:  Peter T Nelson; Erin L Abner; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Karen Santacruz; Charles D Smith; Ela Patel; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-07       Impact factor: 3.685

Review 7.  Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.

Authors:  Peter T Nelson; Heiko Braak; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

8.  Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Authors:  Stephen W Scheff; Mubeen A Ansari; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

9.  Does Alzheimer's disease begin in the brainstem?

Authors:  G Simic; G Stanic; M Mladinov; N Jovanov-Milosevic; I Kostovic; P R Hof
Journal:  Neuropathol Appl Neurobiol       Date:  2009-08-04       Impact factor: 8.090

10.  Brain homogenates from human tauopathies induce tau inclusions in mouse brain.

Authors:  Florence Clavaguera; Hiroyasu Akatsu; Graham Fraser; R Anthony Crowther; Stephan Frank; Jürgen Hench; Alphonse Probst; David T Winkler; Julia Reichwald; Matthias Staufenbiel; Bernardino Ghetti; Michel Goedert; Markus Tolnay
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.